These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17369525)

  • 1. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
    Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS
    Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
    Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC
    J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
    Kaidanovich-Beilin O; Eldar-Finkelman H
    J Pharmacol Exp Ther; 2006 Jan; 316(1):17-24. PubMed ID: 16169938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.
    Liang Y; Osborne MC; Monia BP; Bhanot S; Watts LM; She P; DeCarlo SO; Chen X; Demarest K
    Metabolism; 2005 Jul; 54(7):848-55. PubMed ID: 15988691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
    Irwin N; McClean PL; Flatt PR
    J Pept Sci; 2007 Jun; 13(6):400-5. PubMed ID: 17486662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
    Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
    Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.
    Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H
    Eur J Pharmacol; 2008 Jul; 588(2-3):325-32. PubMed ID: 18499100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
    Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes.
    Soltani N; Kumar M; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jun; 14(12):981-8. PubMed ID: 17410180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1.
    Liu MJ; Shin S; Li N; Shigihara T; Lee YS; Yoon JW; Jun HS
    Mol Ther; 2007 Jan; 15(1):86-93. PubMed ID: 17164779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in mice.
    Riedel MJ; Lee CW; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E936-44. PubMed ID: 19190262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector.
    Choi SH; Lee HC
    Gene Ther; 2011 Feb; 18(2):155-63. PubMed ID: 20720576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glucagon-like peptide-1 gene expression on graft function in mouse islet transplantation.
    Chae HY; Kang JG; Kim CS; Lee SJ; Lee M; Kang D; Jun HS; Ihm SH
    Transpl Int; 2012 Feb; 25(2):242-9. PubMed ID: 22171669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exercise reduces insulin resistance-induced TRB3 expression and amelioration of the hepatic production of glucose in the liver of diabetic mice.
    Lima AF; Ropelle ER; Pauli JR; Cintra DE; Frederico MJ; Pinho RA; Velloso LA; De Souza CT
    J Cell Physiol; 2009 Oct; 221(1):92-7. PubMed ID: 19492410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4 and exercise improve hepatic glucose homeostasis by promoting insulin signaling in diabetic rats.
    Park S; Hong SM; Ahn IS
    Metabolism; 2010 Jan; 59(1):123-33. PubMed ID: 19766272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
    Green BD; Irwin N; Cassidy RS; Gault VA; Flatt PR
    Peptides; 2006 Sep; 27(9):2343-9. PubMed ID: 16730098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
    Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM
    Nature; 2001 Sep; 413(6852):131-8. PubMed ID: 11557972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.